Bio-Techne Corporation (TECH)
NASDAQ: TECH
· Real-Time Price · USD
62.94
0.85 (1.37%)
At close: Oct 03, 2025, 3:59 PM
61.76
-1.87%
After-hours: Oct 03, 2025, 07:07 PM EDT
Bio-Techne Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Consumables Revenue | 252.94M | 257.79M | 230.72M | 230.84M | 245.78M | 246.73M | 211.13M | 224.55M |
| Consumables Revenue Growth | -1.88% | +11.73% | -0.06% | -6.07% | -0.39% | +16.86% | -5.98% | n/a |
| Instruments Revenue | 28.9M | 26.11M | 30.87M | 26.21M | 27.09M | 26.49M | 29.82M | 24.86M |
| Instruments Revenue Growth | +10.69% | -15.41% | +17.79% | -3.27% | +2.26% | -11.17% | +19.97% | n/a |
| Royalty Revenue | 5.51M | 5.04M | 8.1M | 5.05M | 5.05M | 4.7M | 7.52M | 6.07M |
| Royalty Revenue Growth | +9.27% | -37.77% | +60.36% | -0.02% | +7.42% | -37.46% | +23.77% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Apac, Excluding Greater China Revenue | 18.89M | 21.25M | 19.01M | 18.12M | 19.26M | 18.25M | 19.04M | 17.35M |
| Apac, Excluding Greater China Revenue Growth | -11.10% | +11.76% | +4.90% | -5.90% | +5.51% | -4.14% | +9.75% | n/a |
| C N Revenue | 26.91M | 24.48M | 24.75M | 24.32M | 63.56M | 60.53M | 62.54M | 54.8M |
| C N Revenue Growth | +9.89% | -1.09% | +1.78% | -61.74% | +5.01% | -3.21% | +14.12% | n/a |
| Europe Revenue | 70.35M | 66.5M | 70.39M | 59.06M | 23.93M | 25.6M | 24.46M | 25.48M |
| Europe Revenue Growth | +5.79% | -5.53% | +19.18% | +146.87% | -6.54% | +4.66% | -4.03% | n/a |
| Rest Of World Revenue | 9.65M | 9.18M | 9.73M | 8.99M | 10.05M | 10.61M | 8.09M | 7.75M |
| Rest Of World Revenue Growth | +5.12% | -5.62% | +8.15% | -10.54% | -5.22% | +31.10% | +4.44% | n/a |
| United Kingdom Revenue | 14.79M | 12.85M | 13.24M | 13.94M | 177.53M | 173.31M | 147.79M | 159.1M |
| United Kingdom Revenue Growth | +15.06% | -2.95% | -5.03% | -92.15% | +2.43% | +17.27% | -7.11% | n/a |
| U S Revenue | 176.39M | 181.92M | 159.91M | 165.01M | n/a | n/a | n/a | n/a |
| U S Revenue Growth | -3.04% | +13.77% | -3.10% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 23.22M | 151.27M | 121.45M | 119.16M | 101.9M | 107.5M | 115.67M | 105.33M | 86.75M | 99.24M | 93.01M | 99.38M | 96.63M | 89.27M | 100.69M | 86.17M | 86.64M | 82.6M | 83.12M | 72.6M | 57.22M | 66.32M | 68.03M | 69.01M | 68.74M | 64.97M | 63.6M | 67.05M | 65.29M | 53.28M | 63.77M | 58.29M | 47.2M | 48.11M | 55.66M | 46.26M | 38.04M | 35.22M | 34.59M | 33.04M | 30.47M | 29.09M |
| Selling, General, and Administrative Revenue Growth | -84.65% | +24.55% | +1.92% | +16.94% | -5.22% | -7.06% | +9.81% | +21.41% | -12.58% | +6.70% | -6.41% | +2.84% | +8.25% | -11.35% | +16.85% | -0.54% | +4.90% | -0.63% | +14.49% | +26.87% | -13.71% | -2.52% | -1.42% | +0.40% | +5.80% | +2.15% | -5.14% | +2.70% | +22.52% | -16.45% | +9.41% | +23.50% | -1.89% | -13.56% | +20.30% | +21.63% | +8.01% | +1.83% | +4.68% | +8.42% | +4.76% | n/a |
| Research and Development Revenue | 26.03M | 24.58M | 25.02M | 23.87M | 23.99M | 25.76M | 22.92M | 24M | 23.42M | 22.71M | 22.46M | 23.9M | 23.15M | 21.74M | 20.65M | 21.6M | 20.72M | 17.05M | 16.79M | 16.04M | 16.78M | 15.95M | 16.38M | 16.08M | 16.26M | 15.55M | 15.81M | 14.79M | 13.98M | 13.89M | 13.91M | 13.55M | 13.7M | 13.77M | 13.28M | 12.77M | 11.64M | 11.24M | 10.98M | 11.32M | 10.81M | 10.87M |
| Research and Development Revenue Growth | +5.91% | -1.75% | +4.81% | -0.50% | -6.88% | +12.41% | -4.51% | +2.47% | +3.11% | +1.13% | -6.04% | +3.26% | +6.47% | +5.29% | -4.40% | +4.24% | +21.52% | +1.57% | +4.66% | -4.40% | +5.17% | -2.61% | +1.89% | -1.12% | +4.55% | -1.64% | +6.92% | +5.79% | +0.63% | -0.14% | +2.68% | -1.09% | -0.54% | +3.69% | +4.04% | +9.64% | +3.54% | +2.44% | -3.05% | +4.71% | -0.48% | n/a |